USA flag logo/image

An Official Website of the United States Government

PURIFICATION OF HUMAN PLATELET DERIVED GROWTH FACTOR RECEPTOR

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
8067
Program Year/Program:
1988 / SBIR
Agency Tracking Number:
8067
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
ONCOGENE SCIENCE, INC.
106 CHARLES LINBERGH BLVD Uniondale, NY 11553
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 1988
Title: PURIFICATION OF HUMAN PLATELET DERIVED GROWTH FACTOR RECEPTOR
Agency: HHS
Contract: N/A
Award Amount: $50,000.00
 

Abstract:

THE TWO MOST PREVALENT CAUSES OF DEATH IN WESTERN CIVILIZATION ARE MYOCARDIAL AND CEREBRAL INFARCATIONS. THESE CONDITIONS ARE PRIMARILY THE RESULT OF ATHEROSCLEROTICLESIONS WHICH THE BLOOD VESSELS SUPPLYING THE HEART AND BRAIN. CONSIDERABLE EVIDENCE HAS NOW ACCUMULATED WHICH SUGGEST THAT PLATELET-DERIVED GROWTH FACTOR (PDGF) STIMULATES THE GROWTH OF THE CELLS WHICH FORM THESE LESIONS. LOCALIZED HIGH CONCENTRATIONS OF PDGF ARE THOUGHT TO ARISE AT THE LESIONS DUE TO ITS RELEASE FROM DAMAGED ENDOTHELIUM AND ADHERING PLATELETS AT THE LESION SITE. PDGFEXERTS ITS MITOGENIC EFFECT ON CELLS THROUGH A SPECIFIC PLASMA MEMBRANE PDGF RECEPTOR PROTEIN-TYROSINE KINASE. THE ULTIMATE OBJECTIVE OF THE PROPOSED PROJECT IS TO FIND SPECIFIC INHIBITORS OF PDGF RECEPTOR KINASE ACTIVITY FOR EVALUATION AS THERAPEUTIC DRUGS IN THE TREATMENT OF ATHEROSCLEROSIS. IN ORDER TO DO THIS, PHASE I OF THE PROJECT WILL PURIFY THE HUMAN PDGF-RECEPTOR AND DEVELOP AN ASSAY FOR PDGF-DEPENDENT, PDGF RECEPTOR PROTEIN-TYROSINE KINASE ACTIVITY, WHICH IS CAPABLE OF BEING AUTOMATED SO THATLARGE NUMBERS OF POTENTIAL INHIBITOR COMPOUNDS CAN BE SCREENED. THE POTENTIAL IMPORTANCE OF FINDING A DRUG WHICH INHIBITS PDGF ACTION IS UNDERLINED BY THE FACT THAT ANNUALLYIN THE USA ALONE ABOUT 765,000 PEOPLE DIE OF HEART DISEASE, AND 154,000 OF CEREBROVASCULAR DISEASES.

Principal Investigator:


0

Business Contact:

Small Business Information at Submission:

Oncogene Science Inc
350 Community Dr Manhasset, NY 11030

EIN/Tax ID:
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No